As technology in rare disease accelerates, and with topics like drug pricing being a top priority in government, we must act now to drive innovation and collaboration to develop stronger resources, better outcomes and find cures for the community.
Creating a Stronger Future with The New York Labor Health Care Alliance
Read More
Creating a Stronger Future with LaboreRx
Read MoreCreating a stronger future with SMART Coalition
Read More
Physician Engagement
A better patient experience begins in the doctor’s office. To make that experience more effective and efficient, we empower physicians to make the best prescribing decisions in real time.

Lowering Costs
Lowering costs while providing high-quality care shouldn’t require compromises.

Managing Complex & Chronic Disease
Health care remains uncoordinated and costly. Consider diabetes, one of the most expensive conditions to manage. Prevalence continues to rise, despite advancements.

ScriptVision Gives Physicians Real-Time Access to Patient-Specific Information
Now in beta testing, the app is a new addition to our suite of provider solutions.
Read More
How to Always Improve Good Utilization Management
Utilization management protects plan sponsors financially while providing a seamless member and prescriber experience.
Read More
Digital Solutions Are Just One Way to Help Ease Physicians' Burden
More than half of physicians report having less free time than when they first started practicing. We're creating a simpler pharmacy experience to reduce administrative burden.
Read More
Smart Decisions Made Simple
The mobile app offers a more personalized experience for members, providing on-the-go access to benefit information.
Read More
Helping Physicians by Creating a Simpler Pharmacy Experience
Industry leading, data-driven tools and programs help prescribers make the best therapy decisions for patients at the point-of-care.
Read More
SafeGuardRx Enhancements: Further Optimizing Care and Value
Expanded discounts, pharmacogenomic testing and innovative patient engagement tools offered by three SafeGuardRx® programs.
Read More
PCSK9 Therapy: An Example of Value-Based Care
Working with Regeneron and Sanofi, Express Scripts directly delivers drug-specific savings to patients, making PCSK9 therapy more affordable and more accessible.
Read More
An Affordable Alternative for Daraprim: $1 per Pill
Express Scripts and Imprimis Pharmaceuticals champion the needs of patients who can't pay $750 for a single pill.
Read More
2020 National Preferred Formulary: Improving Care and Value
Plan sponsors and members want the most clinically appropriate prescription drug coverage at the best value.
Read More
Improving Health Care With Physician Connectivity
Technology helps physicians quickly and easily make the best clinical and most affordable prescribing decisions for their patients.
Read More
FDA Approved Drugs: October 2020
The Express Scripts Office of Clinical Evaluation and Policy tracks some recent updates to the drug pipeline.
Read More
FDA Approved Drugs: February 2020
The Express Scripts Office of Clinical Evaluation and Policy tracks some recent updates to the drug pipeline.
Read More
Guaranteed Savings in Uncertain Times
When the only constant is change, the comprehensive Medical Drug Management program delivers guaranteed savings.
Read More
FDA Approved Drugs: December 2020
The Express Scripts Office of Clinical Evaluation and Policy lists the drugs that were approved by the Food and Drug Administration (FDA) in November 2020.
Read More
FDA Approved Drugs: April 2020
The Express Scripts Office of Clinical Evaluation and Policy tracks some recent updates to the drug pipeline.
Read More
FDA Approved Drugs: January 2021
The Express Scripts Office of Clinical Evaluation and Policy lists the drugs that were approved by the Food and Drug Administration (FDA) in December 2020.
Read More
FDA Approved Drugs: March 2020
The Express Scripts Office of Clinical Evaluation and Policy tracks some recent updates to the drug pipeline.
Read More
FDA Approved Drugs: June 2020
The Express Scripts Office of Clinical Evaluation and Policy tracks some recent updates to the drug pipeline.
Read More